- Corporate Officers - D
- Dawes Karen A
Insider Trading History of Dawes Karen A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dawes Karen A since 2006.
This trader's CIK number is 1261506.
At the time of last reporting, Dawes Karen A was the Officer of Repligen Corp. (stock ticker symbol RGEN).
Also see all insider trading activities at Repligen Corp.
Note that in the past
DAWES KAREN A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Repligen Corp (RGEN) by Dawes Karen A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | RGEN | 0 | $0 | 1,000 | $193,350 | 7,579 | $394,562 |
| 2022 | RGEN | 0 | $0 | 14,715 | $2,223,407 | 0 | $0 |
| 2021 | RGEN | 0 | $0 | 36,262 | $9,155,367 | 26,171 | $427,946 |
| 2020 | RGEN | 0 | $0 | 37,022 | $4,122,100 | 20,000 | $66,000 |
| 2019 | RGEN | 0 | $0 | 1,295 | $100,168 | 20,000 | $99,200 |
| 2018 | RGEN | 0 | $0 | 20,000 | $835,939 | 20,000 | $101,600 |
| 2017 | RGEN | 0 | $0 | 2,521 | $86,016 | 20,000 | $85,800 |
| 2016 | RGEN | 0 | $0 | 0 | $0 | 15,000 | $46,500 |
| 2013 | RGEN | 1,000 | $7,700 | 0 | $0 | 0 | $0 |
| 2011 | RGEN | 14,500 | $50,952 | 0 | $0 | 0 | $0 |
| 2008 | RGEN | 2,000 | $7,000 | 0 | $0 | 0 | $0 |
| 2006 | RGEN | 2,000 | $6,660 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Assertio Therapeutics, Inc (ASRT) by Dawes Karen A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ASRT | 0 | $0 | 15,834 | $12,524 | 0 | $0 |
| 2019 | ASRT | 0 | $0 | 12,500 | $39,800 | 31,250 | $0 |
| 2018 | ASRT | 0 | $0 | 8,421 | $40,723 | 15,000 | $22,350 |
| 2013 | ASRT | 2,000 | $11,920 | 0 | $0 | 0 | $0 |
| 2011 | ASRT | 1,000 | $8,228 | 0 | $0 | 0 | $0 |
| 2008 | ASRT | 5,000 | $7,200 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Pdl Biopharma, Inc. (PDLI) by Dawes Karen A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | PDLI | 0 | $0 | 0 | $0 | 250 | $3,387 |
Insider trading activities at 3 companies by Dawes Karen A:
1. Repligen Corp (RGEN)
2. Assertio Therapeutics, Inc (ASRT)
3. Pdl Biopharma, Inc. (PDLI)
Table 1. Insider trading of Repligen Corp (RGEN) by Dawes Karen A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-14 | RGEN | Option Ex | 2,953 | 67.71 | 199,947 |
| 2024-02-27 | RGEN | Option Ex | 4,626 | 42.07 | 194,615 |
| 2024-02-27 | RGEN | Sale | 1,000 | 193.35 | 193,350 |
| 2022-05-25 | RGEN | Sale | 14,715 | 151.10 | 2,223,407 |
| 2021-11-10 | RGEN | Sale | 4,783 | 265.15 | 1,268,226 |
| 2021-11-10 | RGEN | Option Ex | 4,783 | 26.12 | 124,931 |
| 2021-11-02 | RGEN | Sale | 2,400 | 303.19 | 727,646 |
| 2021-09-14 | RGEN | Sale | 274 | 293.45 | 80,405 |
| 2021-09-01 | RGEN | Option Ex | 3,459 | 38.76 | 134,070 |
| 2021-09-01 | RGEN | Sale | 3,459 | 283.02 | 978,966 |
| 2021-08-17 | RGEN | Sale | 17,514 | 253.67 | 4,442,723 |
| 2021-08-18 | RGEN | Sale | 1,442 | 259.94 | 374,839 |
| 2021-07-20 | RGEN | Sale | 4,585 | 201.69 | 924,771 |
| 2021-07-13 | RGEN | Option Ex | 2,929 | 41.19 | 120,645 |
| 2021-07-13 | RGEN | Sale | 1,520 | 202.23 | 307,389 |
| 2021-05-11 | RGEN | Option Ex | 15,000 | 3.22 | 48,300 |
| 2021-05-11 | RGEN | Sale | 285 | 176.85 | 50,402 |
| 2020-06-18 | RGEN | Sale | 18,705 | 115.10 | 2,152,908 |
| 2020-05-20 | RGEN | Sale | 517 | 138.15 | 71,420 |
| 2020-05-18 | RGEN | Sale | 1,600 | 139.30 | 222,884 |
| 2020-04-20 | RGEN | Option Ex | 8,200 | 3.30 | 27,060 |
| 2020-04-21 | RGEN | Option Ex | 11,800 | 3.30 | 38,940 |
| 2020-04-20 | RGEN | Sale | 12,200 | 104.70 | 1,277,340 |
| 2020-02-21 | RGEN | Sale | 4,000 | 99.39 | 397,548 |
| 2019-06-17 | RGEN | Option Ex | 20,000 | 4.96 | 99,200 |
| 2019-06-17 | RGEN | Sale | 1,295 | 77.35 | 100,168 |
| 2018-05-11 | RGEN | Option Ex | 20,000 | 5.08 | 101,600 |
| 2018-05-11 | RGEN | Sale | 20,000 | 41.80 | 835,939 |
| 2017-03-21 | RGEN | Sale | 2,521 | 34.12 | 86,016 |
| 2017-03-21 | RGEN | Option Ex | 20,000 | 4.29 | 85,800 |
| 2016-06-27 | RGEN | Option Ex | 15,000 | 3.10 | 46,500 |
| 2013-06-21 | RGEN | Buy | 1,000 | 7.70 | 7,700 |
| 2011-08-12 | RGEN | Buy | 10,000 | 3.50 | 34,950 |
| 2011-06-14 | RGEN | Buy | 4,500 | 3.56 | 16,002 |
| 2008-12-01 | RGEN | Buy | 2,000 | 3.50 | 7,000 |
| 2006-09-01 | RGEN | Buy | 2,000 | 3.33 | 6,660 |
Table 2. Insider trading of Assertio Therapeutics, Inc (ASRT) by Dawes Karen A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-05-08 | ASRT | Sale | 15,834 | .79 | 12,524 |
| 2019-06-13 | ASRT | Sale | 12,500 | 3.18 | 39,800 |
| 2019-05-08 | ASRT | Option Ex | 31,250 | .00 | 0 |
| 2018-12-03 | ASRT | Option Ex | 15,000 | 1.49 | 22,350 |
| 2018-12-03 | ASRT | Sale | 8,421 | 4.84 | 40,723 |
| 2013-03-06 | DEPO | Buy | 2,000 | 5.96 | 11,920 |
| 2011-06-14 | DEPO | Buy | 1,000 | 8.23 | 8,228 |
| 2008-12-01 | DEPO | Buy | 5,000 | 1.44 | 7,200 |
Table 3. Insider trading of Pdl Biopharma, Inc. (PDLI) by Dawes Karen A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-04-29 | PDLI | Option Ex | 250 | 13.55 | 3,387 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Dawes Karen A
(Officer of Repligen Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.